1303967-81-8

Basic information

• Product Name: tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate
• Synonyms: tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 2-[[(1-methylethyl)amino]methyl]-, 1,1-dimethylethyl ester
• CAS NO: 1303967-81-8
• Molecular Formula: C13H26N2O2
• Molecular Weight: 242
• Mol File: 1303967-81-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate(1303967-81-8)
• EPA Substance Registry System: tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate(1303967-81-8)

Safety Data

• Hazardous Substances Data: 1303967-81-8(Hazardous Substances Data)

Usage

Description

Tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate is a chemical compound with potential pharmaceutical applications, characterized by its pyrrolidine derivative structure and the presence of a tert-butyl ester group. The incorporation of an isopropylamino group within its molecular framework suggests possible pharmacological activity, particularly in relation to the central nervous system. Its unique structural features and potential biological activity make it a promising candidate for medicinal chemistry research and drug development.

Uses

Used in Pharmaceutical Industry:
Tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate is used as a precursor in the synthesis of pharmaceutical compounds for its potential central nervous system activity. Its unique structural elements, including the tert-butyl ester and isopropylamino groups, may contribute to the development of new drugs with specific therapeutic targets.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, tert-butyl 2-((isopropylamino)methyl)pyrrolidine-1-carboxylate serves as a valuable compound for exploring its potential biological activities and interactions with biological targets. Its structural features may offer insights into the design of novel therapeutic agents with improved efficacy and selectivity.
Further studies are required to elucidate the full spectrum of its properties and to assess its suitability for various applications in pharmacology. The exploration of its potential may lead to the discovery of new therapeutic agents or the enhancement of existing drug formulations.

Upstream product

• 67-64-1 acetone 
• 259537-92-3 tert-butyl (2R)-2-(aminomethyl)pyrrolidine-1-carboxylate 

Relevant articles and documents

SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present invention relates to compounds having the general formula (I) or a pharmaceutically acceptable salt thereof, wherein Rl is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6balkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.